Raised insulin link to breast cancer in obese women

Raised insulin levels may account for much of the increased risk of breast cancer among obese women.

US researchers analysed blood samples from 1,651 postmenopausal women enrolled in the Women’s Health Initiative Observation Study. High fasting insulin levels were associated with a 46% greater risk of developing breast cancer.

High estrogen levels were also associated with an increased cancer risk. Levels of estrogen and insulin tend to be higher in obese women and this may largely explain the association between obesity and breast cancer, the researchers say.

Interventions aimed at cutting fasting insulin levels may reduce breast cancer risk among postmenopausal women, the researchers suggest. Previous studies have supported a role for insulin in the development of breast cancer, they point out.

tom.moberly@haymarket.com

Comment below and tell us what you think

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus